Document is current
Any future updates will be listed below
-
Authors
Okoev, Grigori https://orcid.org/0000-0003-3439-4362
Weisdorf, Daniel J. https://orcid.org/0000-0001-8078-8579
Wagner, John E.
Blazar, Bruce R.
MacMillan, Margaret L. https://orcid.org/0000-0002-0755-0852
DeFor, Todd
Lazaryan, Aleksandr
El Jurdi, Najla
Holtan, Shernan G.
Brunstein, Claudio G. https://orcid.org/0000-0002-1997-3799
Betts, Brian C.
Takahashi, Takuto https://orcid.org/0000-0001-8296-6412
Bachanova, Veronika https://orcid.org/0000-0002-9325-432X
Warlick, Erica D.
Rashidi, Armin
Arora, Mukta
- License Information
-
More Information
Article History
Received: 7 July 2020
Revised: 26 November 2020
Accepted: 8 December 2020
First Online: 8 January 2021
Compliance with ethical standards
:
: DJW - research support from Incyte. JEW - advisor at Magenta Therapeutics. BRB - founder of Tmunity Therapeutics, advisory board member for Kadmon Pharmaceuticals, Magenta Therapeutics, and BlueRock Therapeutics and receives research funding from BlueRock Therapeutics. SGH – consultant for Incyte, Bristol Meyers Squibb, and Generon.
